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Identity 
Other names: FB1 
HGNC (Hugo): TFPT 
Location: 19q13.4 
 




Genomic structure of six exons and five introns 
spanning about 10 kb. 
Transcription 
Two transcripts of 1.1 kb and 1.2 kb, expressed mainly 
in brain and in hemopoietic cell lines. The rat ortholog, 
Amida, was found highly expressed also in rat testis. 
TATA less promoter, that can be transactivated "in 
vitro" by PU.1 and Ikaros 2. Orientation, minus strand. 
Protein 
Description 
Conserved protein of 253 amino acids (in man) with 
two nuclear localization signals (NLS) (n.68-75 and 
n.190-194) and a DNA binding domain located 






Overexpression of TFPT/Amida in cultured cells 
induces arrest in G2-M and apoptosis. Biochemical 
studies indicate that TFPT/Amida interacts with 
Cdc2/CDK1 in mitosis and its overexpression results in 
a decrease of Cdc2/CDK1 activity (5).It is also 
suggested that the TFPT/Amida DNA binding activity 
is necessary for cell cycle inhibition and that Amida 
phophorylation by Cdc2/CDK1, detected "in vitro", 
might decrease this DNA binding activity. 
Homology 
Very high homology with mouse and rat orthologs. 
Mutations 
Somatic 
Involved in chromosome rearrangement in leukaemia. 
Implicated in 
Childhood pre-B ALL 
Note 
We detected 8 cases out of 200: incidence about 4% of 
childhood pre-B ALL. 
Cytogenetics 
Following the position of the two involved genes, E2A 
on 19p13 and FB1 on 19q13 an inv(19)(p13q13) 
appears more likely but a translocation 





Since the chimeric transcripts so far analyzed contain  
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the FB1 sequence fused out of frame to E2A and no 
truncated E2A protein was detected by Western blot, 
we suggest that no fusion protein is produced. 
Breakpoints 
Note 
We detected different joining points in the transcripts 
of the different analyzed cases indicating different 
breakpoints in a genomic region spanning exons 15-17 
on TCF3 and exons 5-6 on TFPT. 
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